2 results
Approved WMOCompleted
The primary objective is to evaluating the impact of treatment on subject reported outcomes of their satisfaction and experience of treatment with VOLUMA® with Lidocaine (2ml or 1ml or a combination of both), for the mid-face area volume enhancement…
Approved WMOCompleted
Demonstrate an increase of 2-year overall survival (OS) of 15 % (from 50% to 65 %) vs historical controls of the addition of nitroglycerin to radiotherapy (±chemotherapy) of stage I-IV NSCLC.